CAS: 89-58-7; 1,4-Dimethyl-2-Nitrobenzene

该化合物是一种芳香化合物,其特点是以两个甲基组和一个硝基组取代一个苯环,甲基组位于1和4个位置,硝基组位于2个位置,使其成为一个分解的硝基苯衍生物.该化合物一般是黄色晶体固体,以其在乙醇和乙醇等有机溶剂中的中等溶解性而闻名,但水溶性有限.该化合物有独特的芳香味,用于各种化学合成,包括染料和药品的生产.该硝基组的存在具有重要的再活动性,使其在有机合成中成为有用的中间体.此外,1,4-二甲基-2-硝基苯在使用和处置过程中可能对环境和健康造成危害,需要谨慎处理和遵守安全协议.

结构式图片

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

para-xylene 4-nitro-2,5-xylidine methanol (E)-1,4-dimethyl-4-nitr°Cyclohexa-2,5-dien-1-ol 2-nitroterephthalic acid 2,5-Dimethylaniline 2,5-dimethyl-1,3-dinitrobenzene 2,3-dinitro-p-xylene

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6432933-B1
    优先权日:1997-07-07
    标 题 :Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
    发明人:CARROLL CAROLYN DIIANNI; DOLLE III ROLAND ELLWOOD; SHIMSHOCK YVONNE CLASS; HERPIN TIMOTHEE FELIX
    权利人:PHARMACOPEIA INC
    摘要:Compounds of Formula I n are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or α-hydroxyamide group and Z is an acyl or α-ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.

    专利号:US-RE42890-E
    优先权日:2003-05-23
    标题 :Furazanobenzimidazoles
    发明人:EBERLE MARTIN; BACHMANN FELIX; STREBEL ALESSANDRO; ROY SUBHO; SRIVASTAVA SUDHIR; SAHA GOUTAM
    权利人:BASILEA PHARMACEUTICA AG
    摘要:The invention relates to compounds of formula (I) wherein R represents aryl or heteroaryl, X is oxygen, a carbonyl group, an oxime derivative of a carbonyl group or an α,β-unsaturated carbonyl group, and the substituents R 1 to R 6 have the meanings given in the specification, for use as medicaments, to novel compounds of formula (I), to methods of synthesis of such compounds, to pharmaceutical compositions containing compounds of formula (I), to the use of a compounds of formula (I) for the preparation of a pharmaceutical composition for the treatment of neoplastic and autoimmune diseases, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same

    专利号:US-6852711-B2
    优先权日:1998-09-11
    标题:HIV protease inhibitors
    发明人:BOYER JR FREDERICK EARL; DOMAGALA JOHN MICHAEL; ELLSWORTH EDMUND LEE; GAJDA CHRISTOPHER ANDREW; HAGEN SUSAN ELIZABETH; LOVDAHL MICHAEL JAMES; LUNNEY ELIZABETH ANN; MARKOSKI LARRY JAMES; PRASAD JOSYULA VENKATA NAGENDR; TAIT BRADLEY DEAN
    权利人:AGOURON PHARMA
    摘要:The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.

    专利号:US-4073795-A
    优先权日:1976-06-22
    标 题:Synthesis of tryptophans

    专利号:DE-69202005-T2
    优先权日:1991-06-24
    标 题:Process for the synthesis of symmetrical N, N'-disubstituted aromatic ureas.

    专利号:US-5198582-A
    优先权日:1989-11-02
    标 题 :Process for preparing symmetric N,N'-disubstituted aromatic urea
    发明人:OH JAE S; LEE SANG M
    权利人:LUCKY LTD
    摘要:A process for preparing N,N'-disubstituted urea derivatives of the following formula (I) ##STR1## wherein Ar represents an unsubstituted aromatic radical or an aromatic radical substituted with a halogen atom, an alkyl group, or an alkoxy group, which comprises reacting an aromatic mono-nitro compound, an aromatic primary amine, and synthesis gas in the presence of a catalyst consisting essentially of a divalent palladium compound as a main catalyst component and an ammonium or a phosphonium salt containing halogen atom as a co-catalyst component, and a non-polar solvent.
    陕西康源化工有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kangyuanchem.com
    企业联系电话:86-917-8440118👤
    📞陕西康源化工有限责任公司 ⚠️参考联系方式
    联系人:郭永刚
    电话:86-917-8440118
    手机:13709271006
    传真:86-917-8440091
    邮箱:sales@kangyuanchem.com
    通信地址: 陕西省岐山县益店镇
    邮编: 722403
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:陕西省岐山县益店镇
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Prehled Prumyslove Toxikologie; Organicke Latky, Marhold, J., Prague, Czechoslovakia, Avicenum, 1986, -(420), 1986
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知